Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00839189 · ClinicalTrials.gov registry record · Phase 1
Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults
A Phase 1 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
NCT00839189: Completed Phase 1 study, sponsored by University of North Carolina, Chapel Hill.
NCT00839189 is a Phase 1 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 11 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00839189, a Phase 1 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purposes of this pilot safety study are to identify a dose of inhaled Clinical Center Reference Endotoxin (CCRE) that is well tolerated by allergic subjects that induces measurable increases in neutrophil content of induced sputum that can be employed to screen large populations for susceptibility to the inflammatory effect of inhaled endotoxin.
Interventions
- BIOLOGICAL Clinical Center Reference Endotoxin (CCRE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2002-10 |
| Est. Completion | 2006-06 |
| Phase | Phase 1 |
What the finished NCT00839189 record still lists
NCT00839189 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 1 intervention - of which Clinical Center Reference Endotoxin (CCRE) is the first listed.
NCT00839189 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00839189 about?
NCT00839189 is a clinical study titled "Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults". The purposes of this pilot safety study are to identify a dose of inhaled Clinical Center Reference Endotoxin (CCRE) that is well tolerated by allergic subjects that induces measurable increases in neutrophil content of induced sputum that can be employed to screen large populations for susceptibili...
What is the current status of trial NCT00839189?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2002-10. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00839189?
The interventions under investigation include: Clinical Center Reference Endotoxin (CCRE) (BIOLOGICAL).
Who is sponsoring clinical trial NCT00839189?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00839189's enrollment target sits among peer trials
11 1911th of 2000 higher than 88 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia